RECENT NEWS

Thermo Fisher Scientific is to support a new collaborative laboratory and office space for growing biotech businesses in Florida as a founding sponsor. The firm says its involvement with Momentum Labs in Alachua, Florida is part of its efforts to support emerging biotechnology companies as they address key challenges in bringing new therapies to market.

Scientific Laboratory Supplies (SLS) has announced the acquisition of C&M Scientific, a Scotland-based distributor of laboratory equipment and service provider specialising in installation, validation, calibration, repair and ongoing maintenance for scientific equipment.

Isohelix, a UK-based specialist biological sample collection company, has begun the process to gain full regulatory approval of the GeneFix Saliva DNA Collectors from the US Food and Drug Administration (FDA).

Fujifilm Irvine Scientific has launched a new nutrient-based HEK293-specific feed medium, designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.

A major new report on in vitro diagnostics, ‘A Strategic Technology Roadmap’ has been launched, proposing a 10-year strategy to put the UK at the forefront of the industry.

US-based digital pathology and artificial intelligence (AI) firm Paige has announced a collaboration with Microsoft to apply the power of AI to digital pathology images to develop and deliver a new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care.

The North East Innovation Lab is celebrating a two-year milestone birthday and has expanded its work in accelerating the development of diagnostics for a range of virus and health threats.

Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to discover and develop next-generation cancer therapies.

Qiagen has announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.

The National Institutes of Health has awarded eight research grants in the USA, to refine new technologies for early diagnosis of severe illnesses resulting from SARS-CoV-2 infection in children.

European manufacturers of medical devices are set to get more time to prepare for forthcoming regulatory changes, after the European Commission adopted a proposal to delay the changes.

Perspectum, a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer, has completed the first close of its Series C funding round. The new $36 million investment was led by Oppenheimer Holdings. The Series C funding brings the total amount raised since inception to circa $120 million.

Bruker Corporation has announced the acquisition of Acquifer Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy.

Virax Biolabs has launched the distribution of human papillomavirus (HPV) test kits with shipments anticipated in Q1 of 2023 to markets accepting the CE mark, such as the European Union.

Bluestar Genomics has jointly announced the company’s commercialisation of its first test for early detection of pancreatic cancer in high-risk patients, and unveiled a new name, ClearNote Health.

UK registered SMEs can apply for a share of up to £25 million in grants to develop innovative solutions to health and healthcare challenges.

Heska Corporation, a global provider of advanced veterinary diagnostic and specialty products and solutions, has completed the previously announced acquisition of LightDeck Diagnostics, a pioneer in planar waveguide fluorescence immunoassay diagnostics.

A new online tech community has been launched by NHS Digital, aimed at supporting those working to integrate systems with national healthcare services.

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today applauded Congress for reaching an agreement on the Consolidated Appropriations Act of 2023 and recognising that it was not the appropriate mechanism for advancing the Verifying Accurate Leading-edge IVCT Development (VALID) Act.

Thermo Fisher Scientific has announced that it has completed its acquisition of The Binding Site Group, a global leader in specialty diagnostics, from a shareholder group led by European private equity firm Nordic Capital, in an all-cash transaction valued at £2.3 billion.